Publications by authors named "Tetsuo Momma"

Claim this Profile
T
Trimodality Therapy With Iodine-125 Brachytherapy, External Beam Radiation Therapy, and Short- or Long-Term Androgen Deprivation Therapy for High-Risk Localized Prostate Cancer: Results of a Multicenter, Randomized Phase 3 Trial (TRIP/TRIGU0907).
Atsunori Yorozu, Mikio Namiki, Shiro Saito, Shin Egawa, Hiroshi Yaegashi, Tetsuo Momma

Int J Radiat Oncol Biol Phys· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Secondary bladder cancer during long-term follow-up after iodine-125 permanent seed implantation for localized prostate cancer.
Yu Ozawa, Yasuto Yagi, Ken Nakamura, Seiya Hattori, Toru Nishiyama, Tetsuo Momma

Brachytherapy· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of darolutamide in Japanese patients with nonmetastatic castration-resistant prostate cancer: a sub-group analysis of the phase III ARAMIS trial.
Hiroji Uemura, Hisashi Matsushima, Kazuki Kobayashi, Hiroya Mizusawa, Hiroaki Nishimatsu, Tetsuo Momma

Int J Clin Oncol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of prostate verification with implanted gold markers in tissue surrounding the prostate and pelvic bony anatomy for external beam radiation therapy following low-dose-rate brachytherapy: a prospective clinical trial.
Tomoya Kaneda, Toshio Ohashi, Takashi Hanada, Koji Takenaka, Shuichi Nishimura, Tetsuo Momma

J Radiat Res· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sub-classification of patients with intermediate-risk metastatic renal cell carcinoma treated with targeted therapy.
Go Kaneko, Suguru Shirotake, Koshiro Nishimoto, Yasumasa Miyazaki, Keiichi Ito, Tetsuo Momma

Jpn J Clin Oncol· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of inflammatory marker levels one month after the first-line targeted therapy initiation on progression-free survival prediction in patients with metastatic clear cell renal cell carcinoma.
Keiichi Ito, Ayako Masunaga, Nobuyuki Tanaka, Ryuichi Mizuno, Suguru Shirotake, Tetsuo Momma

Jpn J Clin Oncol· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plan reproducibility of intraoperatively custom-built linked seeds compared to loose seeds for prostate brachytherapy.
Tomoya Kaneda, Toshio Ohashi, Masanori Sakayori, Shinya Sutani, Shoji Yamashita, Tetsuo Momma

J Contemp Brachytherapy· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostate-specific antigen nadir within 12 months as an early surrogate marker of biochemical failure and distant metastasis after low-dose-rate brachytherapy or external beam radiotherapy for localized prostate cancer.
Shuichi Nishimura, Toshio Ohashi, Tetsuo Momma, Masanori Sakayori, Takahisa Eriguchi

Cancer Med· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Significance of a frozen section analysis of the ureteral margin in bladder cancer patients treated with radical cystectomy and neoadjuvant chemotherapy.
Kyohei Hakozaki, Eiji Kikuchi, Keishiro Fukumoto, Suguru Shirotake, Yasumasa Miyazaki, Tetsuo Momma

Med Oncol· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative analysis of genitourinary toxicity after iodine-125 brachytherapy for localized prostate cancer: Followup of the International Prostate Symptom Score and Overactive Bladder Symptom Score.
Masanori Sakayori, Toshio Ohashi, Tetsuo Momma, Tomoya Kaneda, Shuichi Nishimura

Brachytherapy· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of neutrophil-to-lymphocyte ratio in patients with metastatic renal cell carcinoma treated with first-line and subsequent second-line targeted therapy: A proposal of the modified-IMDC risk model.
Nobuyuki Tanaka, Ryuichi Mizuno, Yota Yasumizu, Keiichi Ito, Suguru Shirotake, Tetsuo Momma

Urol Oncol· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Second-Line Targeted Therapy Dose Intensity on Patients With Metastatic Renal Cell Carcinoma.
Suguru Shirotake, Yota Yasumizu, Keiichi Ito, Ayako Masunaga, Yujiro Ito, Tetsuo Momma

Clin Genitourin Cancer· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
External Validation of the MSKCC and IMDC Risk Models in Patients Treated with Targeted Therapy as a First-line and Subsequent Second-line Treatment: A Japanese Multi-institutional Study.
Nobuyuki Tanaka, Ryuichi Mizuno, Keiichi Ito, Suguru Shirotake, Yota Yasumizu, Tetsuo Momma

Eur Urol Focus· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of reclassification of the IMDC model in patients with metastatic renal cell carcinoma treated with targeted therapy in the first-line and second-line settings.
Nobuyuki Tanaka, Ryuichi Mizuno, Suguru Shirotake, Keiichi Ito, Yota Yasumizu, Tetsuo Momma

Urol Oncol· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-institutional retrospective analysis of learning curves on dosimetry and operation time before and after introduction of intraoperatively built custom-linked seeds in prostate brachytherapy.
Hiromichi Ishiyama, Takefumi Satoh, Atsunori Yorozu, Shiro Saito, Masaaki Kataoka, Tetsuo Momma

J Radiat Res· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of genitourinary and gastrointestinal toxicity among four radiotherapy modalities for prostate cancer: Conventional radiotherapy, intensity-modulated radiotherapy, and permanent iodine-125 implantation with or without external beam radiotherapy.
Shinya Sutani, Toshio Ohashi, Masanori Sakayori, Tomoya Kaneda, Shoji Yamashita, Tetsuo Momma

Radiother Oncol· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of an adjuvant chemotherapeutic regimen on the clinical outcome in high risk patients with upper tract urothelial carcinoma: a Japanese multi-institution experience.
Suguru Shirotake, Eiji Kikuchi, Nobuyuki Tanaka, Kazuhiro Matsumoto, Yasumasa Miyazaki, Tetsuo Momma

J Urol· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multi-institutional validation of the prognostic value of the neutrophil-to-lymphocyte ratio for upper tract urothelial carcinoma treated with radical nephroureterectomy.
Nobuyuki Tanaka, Eiji Kikuchi, Kent Kanao, Kazuhiro Matsumoto, Suguru Shirotake, Tetsuo Momma

Ann Surg Oncol· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Independent predictors for bladder outcomes after treatment of intravesical recurrence following radical nephroureterectomy in patients with primary upper tract urothelial carcinoma.
Nobuyuki Tanaka, Eiji Kikuchi, Kent Kanao, Kazuhiro Matsumoto, Suguru Shirotake, Tetsuo Momma

Ann Surg Oncol· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metastatic behavior of upper tract urothelial carcinoma after radical nephroureterectomy: association with primary tumor location.
Nobuyuki Tanaka, Eiji Kikuchi, Kent Kanao, Kazuhiro Matsumoto, Hiroaki Kobayashi, Tetsuo Momma

Ann Surg Oncol· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The predictive value of positive urine cytology for outcomes following radical nephroureterectomy in patients with primary upper tract urothelial carcinoma: a multi-institutional study.
Nobuyuki Tanaka, Eiji Kikuchi, Kent Kanao, Kazuhiro Matsumoto, Suguru Shirotake, Tetsuo Momma

Urol Oncol· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined brachytherapy and external beam radiotherapy without adjuvant androgen deprivation therapy for high-risk prostate cancer.
Toshio Ohashi, Atsunori Yorozu, Shiro Saito, Tetsuo Momma, Toru Nishiyama

Radiat Oncol· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes following iodine-125 prostate brachytherapy with or without neoadjuvant androgen deprivation.
Toshio Ohashi, Atsunori Yorozu, Shiro Saito, Tetsuo Momma, Kazuhito Toya

Radiother Oncol· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dosimetric effects of prone and supine positions on post-implant assessments for prostate brachytherapy.
Toshio Ohashi, Tetsuo Momma, Shoji Yamashita, Kunimitsu Kanai, Yusuke Watanabe

J Contemp Brachytherapy· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient characteristics and outcomes in metastatic upper tract urothelial carcinoma after radical nephroureterectomy: the experience of Japanese multi-institutions.
Nobuyuki Tanaka, Eiji Kikuchi, Kent Kanao, Kazuhiro Matsumoto, Hiroaki Kobayashi, Tetsuo Momma

BJU Int· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis